Pioneering method of treating Alzheimer’s discredited by scientists
Bexarotene, sold under the name Targretin, had caused ripples of excitement across the medical profession
A drug hailed as a pioneering method of treating Alzheimer’s has been discredited by scientists, after experts were unable to replicate its results this week.
Bexarotene, sold under the name Targretin, had caused ripples of excitement across the medical profession, following high profile research that suggested it could be used to treat the symptoms of Alzheimer’s.
The 2012 research, produced by Gary Landreth and colleagues at Case Western Reserve University in Cleveland and published in Science journal, reported that the drug appeared to reduce the brain plaque build-ups linked to the disease when administered to mice.
Once the results of the study were made public, patients began requesting the drug and some doctors reportedly began prescribing it.
However, a team of experts have now written in the same journal that they have been unable to re-create the results found in the original survey, plunging its validity into doubt.
Sangram Sisodia, professor of neuroscience at the University of Chicago, decided to investigate claims made that the drug could reduce the areas of plaque by 50 per cent within three days, and by 75 per cent in two weeks.
In his replica study published on Thursday, he said: “In view of the significant implications of these landmark findings for the development of novel AD therapeutics, we performed a small pilot study […] using 8-month-old male APP/PS1 mice that were treated orally with a commercial source of bexarotene for seven days.”
Crucially, he said: “We failed to observe any differences in hippocampal or cortical amyloid plaque area or plaque counts between vehicle and bexarotene-treated animals.”
Bexarotene was approved by the FDA in 1999 as a treatment for skin cancer, but has never before been tested as a treatment for humans with Alzheimer’s. Because it has been approved by the FDA it can be prescribed by physicians for use ‘off label.’
However, some scientists argued that whilst the effects on brain plaque had not been replicated, the cognitive improvements had.
Writing in Science, Professor Koldamova said: “We believe these findings make a solid case for continued exploration of bexarotene as a therapeutic treatment for Alzheimer's disease.”
- 1 David Cameron refers to 83-year-old Labour MP Dennis Skinner as 'Jurassic Park'
- 2 Tunisia hotel attack: Locals form 'human shield' to protect hotel from gunman Seifeddine Rezgui
- 3 Optical illusion turns blue demon into brunette
- 4 German ethics council calls for incest between siblings to be legalised by Government
- 5 Saudi Prince Alwaleed bin Talal to donate entire $32bn fortune to charity
Tunisia hotel attack: Locals form 'human shield' to protect hotel from gunman Seifeddine Rezgui
German ethics council calls for incest between siblings to be legalised by Government
Saudi Prince Alwaleed bin Talal to donate entire $32bn fortune to charity
Forget little green men – aliens will look like humans, says Cambridge University evolution expert
Greece debt crisis: Country on course to hold EU referendum as eurozone leaders reject new bailout request
The moment a Queen's Guard soldier lost it and drew his gun at annoying tourist
Greece crisis: IMF was pushed around by Angela Merkel and Nicholas Sarkozy – and now it is being humiliated
Greece crisis: The wider lesson is that it’s time to abandon this failed experiment in currencies
'I wish the BBC would stop calling it Islamic State' – David Cameron unleashes frustration at broadcaster
They are neither a 'state' nor 'Islamic': Why we shouldn't call them Isis, Isil or IS
Girl, 7, stares down hate preacher at Ohio festival with pro-LGBT rainbow flag gesture
£27000 - £30000 per annum: Recruitment Genius: This Edinburgh city centre scho...
£12000 - £24000 per annum: Recruitment Genius: An opportunity has arisen for o...
£35000 - £60000 per annum: Recruitment Genius: This industry leader provides c...
£28000 - £30000 per annum: Recruitment Genius: A Project Coordinator is requir...